This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Coronary Disease - Other

June 27, 2024
This study evaluated the outcomes after the use of cardiac shockwave therapy (SWT) combined with coronary artery bypass surgery (CABG) in patients with reduced left ventricular ejection fraction (LVEF) due to ischemic cardiomyopathy.
June 20, 2024
The prevalence of anomalous aortic origin of a coronary artery is 0.4 percent to 0.8 percent. The decision to operate and choice of procedure can be challenging.
May 18, 2024
Succinct but comprehensive expert viewpoint on Support in Cardiogenic Shock vis -a -vis the manuscript of DanGer trial on promising results of Impella in highly selected subgroup (360 patients in a decade). The important point made is that of careful selection
December 18, 2023
This video demonstrates the short-term safety and efficacy of an emerging operative technique—transconal unroofing of an intraseptal anomalous left coronary artery with patch reconstruction of the right ventricular outflow tract—in a pediatric patient with impaired coronary perfusion.
August 30, 2023
Survival of diabetics after single or multiple coronary artery bypass grafting was compared in a national database over twenty years with 69,224 patients. End points were long-term all-cause mortality and thirty-day clinical outcomes. 17,474 nondiabetic and 10,989 diabetic matched pairs were generated.
August 7, 2023
In a research letter on a small pilot genomic study of sampling coronary atheroma, the authors offer a brief explanation on how their technique can be applied to detect stability of coronary plaque.
August 4, 2023
Authors representing the American Association for Thoracic Surgery and The Society of Thoracic Surgeons published a rebuttal to the Chronic Coronary Disease Guidelines.
January 12, 2023
INTEGRITTY, a group dedicated the appraisal of evidence to support optimized patient management, published a paper highlighting concerns surrounding major TAVR versus SAVR studies. While their findings do not aim to directly discredit the studies, they do raise questions about the integrity of their methodology.
December 1, 2022
This recent JAMA Surgery editorial addresses the controversy associated with the 2021 ACC/AHA/SCAI guidelines on coronary revascularization. It underscores the importance of attention to source data and accurate characterization of evidence.
July 11, 2022
There could be some translational value for cardiovascular surgical practice from this prospective cardiovascular health study. The mechanistic link warrants further investigation and interpretation.